James T Kearns (James Kearns)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 10

Top Venues

BJUI compass

Urology practice

Cancer

Prostate cancer and prostatic diseases

Atrium Health

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Atrium Health Aug 28 2018

United States

Assistant Professor :: Urology

University of Washington Department of Urology Jul 01 2016 - Jun 30 2018

United States

Fellow

University of Chicago Medical Center - Jun 30 2016

United States

Resident :: Urology

University of Illinois at Chicago

United States

Resident :: Urology

Publications

James T Kearns, Brian T Helfand
Is Active Surveillance Too Active? Current urology reports (2023)
Abrar Mian, Jun Wei, Zhuqing Shi, Andrew S Rifkin, S Lilly Zheng, Alexander P Glaser, James T Kearns, Brian T Helfand, Jianfeng Xu
Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort. BJUI compass 4 (2) (2022)
Abrar Mian, Jun Wei, Zhuqing Shi, Andrew S Rifkin, S Lilly Zheng, Alexander P Glaser, James T Kearns, Brian T Helfand, Jianfeng Xu
Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort. BJUI compass 4 (2) (2022)
Abrar Mian, Jun Wei, Zhuqing Shi, Andrew S Rifkin, S Lilly Zheng, Alexander P Glaser, James T Kearns, Brian T Helfand, Jianfeng Xu
Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort. BJUI compass 4 (2) (2022)
James T Kearns, Justin T Matulay, William E Anderson, Timothy C Hetherington, Claud M Grigg, Jason Zhu, Kris E Gaston, Stephen B Riggs, Earle F Burgess, Peter E Clark
Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care System. Urology practice 8 (6) (2021)
James T Kearns, Justin T Matulay, William E Anderson, Timothy C Hetherington, Claud M Grigg, Jason Zhu, Kris E Gaston, Stephen B Riggs, Earle F Burgess, Peter E Clark
Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care System. Urology practice 8 (6) (2021)
Kranthi Sitammagari, Stephanie Murphy, Marc A Kowalkowski, Shih-Hsiung Chou, Matthew Sullivan, Stephanie Taylor, James T Kearns, Thomas Batchelor, Carly Rivet, Colleen Hole, Tony Hinson, Pamela McCreary, Ryan Brown, Todd Dunn, Zeev Neuwirth, Andrew D McWilliams
Insights From Rapid Deployment of a "Virtual Hospital" as Standard Care During the COVID-19 Pandemic. Annals of internal medicine 174 (2) (2020)
Jasmir G Nayak, Nicholas Scalzo, Alice T Chu, Benjamin Shiff, James T Kearns, Geolani W Dy, Liam C Macleod, Matthew Mossanen, William J Ellis, Daniel W Lin, Jonathan L Wright, Lawrence D True, John L Gore
The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study. Prostate cancer and prostatic diseases 23 (1) (2019)
James T Kearns, Sarah K Holt, Jonathan L Wright, Daniel W Lin, Paul H Lange, John L Gore
PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening. Cancer 124 (13) (2018)
James T Kearns, John L Gore
Prostate cancer screening: Do guidelines matter? Cancer 122 (24) (2016)

James T Kearns.css-eqlu8i{font-size:small;padding-left:4px;} (James Kearns)

Publication Activity (10 Years)

Top Topics

Top Venues

James T Kearns (James Kearns)